[1] HOOMES E C. Virology. 1918 and all that [J]. Science, 2004, 303 (5665): 1787-1788.
[2] Public Health information and GIS. Areas with confirmed human cases of H5N1 avain in fluenza since 2003. WHO, 2010,[2010-01-28]. http://www.gamapserver.who.int/mapLibrary/Files/Maps/global_H5H1inHumanCUMULATIVE_FIMS_20100212.png.
[3] DAWOOD F S, JAIN S, FINELLI L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans[J]. N Engl J Med, 2009, 360(25):2605-2615.
[4] DE JONG M D, TRAN T T, TRUONG H K, et al.Oseltamivir resistance during treatment of influenza A(H5N1) infection [J]. N Engl J Med, 2005, 353(25):2667-2672.
[5] ECKERT D M , KIM P S. Mechanisms of viral membrane fusion and its inhibition [J]. Annu Rev Biochem, 2001,70（6）: 777-810.
[6] HAN X, BUSHWELLER J H, CAFISO D S, et al. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin [J]. Nat Struct Biol, 2001, 8(8): 715-720
[7] SKEHEL J. An overview of influenza haemagglutinin and neuraminidase [J]. Biologicals, 2009, 37(3):177-178.
[8] MATROSOVICH M，KLENK H D. Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding [J]. Rev Med Virol, 2003, 13(2): 85-97.
[9] REUTER J D, MYC A, HAYES M M, et al. Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers [J]. Bio Conjug Chem, 1999, 10 (2): 271-278.
[10] LANDERS J J, CAO Z, LEE I, et al. Prevention of influenza pneumonitis by sialic acid conjugated dendritic polymers [J].J Infect Dis, 2002, 186(9): 1222-1230.
[11] JEON S H, KAYHAN B, BEN-YEDIDIA T, et al. A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin [J]. J Biol Chem, 2004, 279(46): 48410-48419.
[12] BELSER J A , LU X, SZRETTER K J, et al. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection[J]. J Infect Dis, 2007, 196(10):1493-1499.
[13] CROSS K J, BURLEIGH L M, STEINHAUER D A. Mechanisms of cell entry by influenza virus [J]. Expert Rev Mol Med, 2001, 3(21):1-18.
[14] EHRHARDT C, HRINCIUS E R, KORTE V, et al. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance [J]. Antiviral Res, 2007, 76(1):38-47.
[15] MINAGAWA K, KOUZUKI S, YOSHIMOTO J, et al. Stachyflin and acetylstachyflin, novel anti-influenza A virus substances, produced by Stachybotrys sp. RF-7260 I. Isolation, structure elucidation and biological activities [J]. J Anti Biot, 2002, 55(2):155-164.
[16] MINAGAWA K, KOUZUKI S, KAMIGAUCHI T. Stachyflin and acetylstachyflin,novel anti-influenza A virus substances, produced by Stachybotrys sp. RF-7260 II. Synthesis and preliminary structure-activity relationships of Stachyflin derivatives [J]. J Antibiot, 2002, 55(2):165-171.
[17] LUO G, TORRI A, HARTE W E, et al. Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus [J]. J Virol, 1997, 71(5):4062-4070.
[18] COMBRINK K D, GULGEZE H B, YU K L, et al. Salicylamide inhibitors of influenza virus fusion [J]. Bioorg Med Chem Lett, 2000, 10(15):1649-1652.
[19] CIANCI C, YU K L, DISCHINO D D, et al. pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion [J]. J Virol, 1999, 73(3):1785-1794
[20] STASCHKE K A, HATCH S D, TANG J C, et al. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid [J]. Virology, 1998, 248(2):264-274.
[21] HOFFMAN L R, KUNTZ I D, WHITEJ M. Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity [J]. Virol, 1997, 71(11): 8808-8820.
[22] RUSSELL R J, KERRY P S, STEVENS D J, et al. Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion[J]. Proc Natl Acad Sci, 2008, 105:17736-17741.
[23] PLOTCH S J, O'HARA B, MORIN J, et al. Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin [J]. J Virol, 1999, 73(1): 140-151.
[24] SONG J M, PARK K D, LEE K H, et al. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives [J].Antiviral Res, 2007, 76(2):178-185.
[25] SMEE D F, BAILEY K W, WONG M H, et al. Treatment of influenza A(H1N1) virus infections in mice and ferrets with cyanovirin-N[J]. Antiviral Res, 2008, 80(3): 266-271.